Waldenström macroglobulinemia: A review of therapy

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations


Waldenström macroglobulinemia is a rare monoclonal gammopathy-associated lymphoplasmacytic lymphoma. Its incidence is only 4 per million per year. This review contains the known published literature specifically on the available management tools for Waldenström macroglobulinemia and is designed to assist clinicians in making management decisions for patients with this uncommon disorder.

Original languageEnglish (US)
Pages (from-to)147-157
Number of pages11
JournalAmerican journal of hematology
Issue number2
StatePublished - Jun 2005


  • Hyperviscosity syndrome
  • Lymphoplasmacytic lymphoma
  • Monoclonal antibody therapy
  • Monoclonal gammopathy
  • Waldenström macroglobulinemia

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Waldenström macroglobulinemia: A review of therapy'. Together they form a unique fingerprint.

Cite this